Orthocell Files Premarket Application With US FDA for Nerve Repair Device; Shares Down 5%

MT Newswires20:32 ET

Orthocell Submits FDA Application for Remplir With Eye on "Largest Healthcare Market in the World"

Investing.com 18:45 ET

Year Wrapped: Orthocell Targets 2025 Growth With FDA Plans & Product Launches | ASX:OCC, OTC:ORHHF

Proactive InvestorsDec 16 21:01 ET

Orthocell Passes Commercialisation Milestone With First Remplir Sales in Singapore

Investing.com Dec 11 19:37 ET

Orthocell Passes Commercialisation Milestone With First Remplir Sales in Singapore | ASX:OCC, OTC:ORHHF

Proactive InvestorsDec 11 19:37 ET

Orthocell Secures First Orders for Nerve Repair Device in Singapore; Shares Up 5%

MT NewswiresDec 11 19:27 ET